These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12394275)

  • 1. Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction.
    Shetty S; Taylor AC; Harris LC
    Anticancer Drugs; 2002 Sep; 13(8):881-9. PubMed ID: 12394275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs.
    McKenzie PP; McPake CR; Ashford AA; Vanin EF; Harris LC
    Mol Cancer Ther; 2002 Oct; 1(12):1097-104. PubMed ID: 12481433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
    McPake CR; Tillman DM; Poquette CA; George EO; Houghton JA; Harris LC
    Oncol Res; 1998; 10(5):235-44. PubMed ID: 9802058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
    Gibson AA; Harwood FG; Tillman DM; Houghton JA
    Clin Cancer Res; 1998 Jan; 4(1):145-52. PubMed ID: 9516963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb.
    Ameyar M; Shatrov V; Bouquet C; Capoulade C; Cai Z; Stancou R; Badie C; Haddada H; Chouaib S
    Oncogene; 1999 Sep; 18(39):5464-72. PubMed ID: 10498900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
    Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC
    Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on MDM2 oncogene expression and its effect on pancreatic carcinoma cells].
    Guo H; Liu T; Gao J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):232-5. PubMed ID: 9275659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting effect of murine double minute-2 oncogene on apoptosis induced by retroviral-mediated wild-type p53.
    Guo H; Liu T; Gao J
    Chin Med J (Engl); 1998 Dec; 111(12):1102-6. PubMed ID: 11263374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
    Taylor AC; Schuster K; McKenzie PP; Harris LC
    Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
    Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
    Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
    Cocker HA; Pinkerton CR; Kelland LR
    Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells.
    Schumacher G; Bruckheimer EM; Beham AW; Honda T; Brisbay S; Roth JA; Logothetis C; McDonnell TJ
    Int J Cancer; 2001 Jan; 91(2):159-66. PubMed ID: 11146439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
    Meng RD; Shih H; Prabhu NS; George DL; el-Deiry WS
    Clin Cancer Res; 1998 Jan; 4(1):251-9. PubMed ID: 9516979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
    Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
    Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.